Cobamamide

腺苷钴胺

Report date: 2023/03/03 20:00:36
NME

Base Information

Drug NameCobamamide
Drug Alias Name腺苷B12辅酶cobamamidecobamamidum腺苷钴铵Dibencozide +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsNot applicable
Therapy Area/IndicationsVitamin B 12 DeficiencyDermatitis, AtopicLeukopenia +[9] 
Global Approved IndicationsVitamin B 12 DeficiencyLeukopeniaAnemia +[8] 
Approved Indications in ChinaLeukopeniaAnemiaNeuritis +[5] 
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesEU +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesHanAll Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEisai Co LtdNorth China Pharmaceutical Kangxin Co Ltd
Inactive CompaniesHanAll Biopharma Co Ltd
Active IndicationsVitamin B 12 DeficiencyLeukopeniaAnemia +[8] 
Inactive IndicationsDermatitis, Atopic

Other Information

ATC CodeB03BA04
Related LinksWikipediaKEGG